James Yan
Chief Tech/Sci/R&D Officer at ZAI LAB LIMITED
Profile
Currently, James Yan is Chief Operating Officer-Research & Development at Zai Lab Ltd. He is also Member of Chinese Society of Toxicology. In his past career he occupied the position of Head-Drug Safety Evaluation at Hutchison MediPharma Ltd. Dr. Yan received a doctorate from Peking Union Medical College.
James Yan active positions
Companies | Position | Start |
---|---|---|
ZAI LAB LIMITED | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Chinese Society of Toxicology | Corporate Officer/Principal | - |
Former positions of James Yan
Companies | Position | End |
---|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2010-12-31 |
Training of James Yan
Peking Union Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ZAI LAB LIMITED | Health Technology |
Private companies | 2 |
---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Chinese Society of Toxicology |
- Stock Market
- Insiders
- James Yan